トップ > 製品検索結果一覧 > Code No. CY-8066 CircuLex CML/Nε-(Carboxymethyl)lysine ELISA Kit

Code No. CY-8066

CircuLex CML/Nε-(Carboxymethyl)lysine ELISA Kit

価格(税別)

¥84,000

在庫

1-9

(2017/06/26 01:30時点)

包装

96 assays

データ

  • Concentrations of CML/Nε-(Carboxymethyl)lysine in patient afflicted lifestyle-related disease and healthy volunteers serum.

キット構成品 CML-BSA coated Microplate, Wash Buffer, Sample Dilution Buffer, Standard Dilution Buffer, CML-HSA Standard, Primary Antibody, HRP conjugated Detection Antibody, Substrate Reagent, Stop Solution
使用目的 This Kit is used for the quantitative measurement of CML-adducts in mammalian serum, plasma, tissue extract and other biological media except rodent specimen.
保存温度 4°C メーカー MBL
サンプル Serum, Plasma, Tissue extract, Other biological media
測定範囲 0.109~7.0 µg/mL
感度 0.063 µg/mL~
関連製品 CY-8067 CircuLex Anti-CML mouse autoantibody ELISA Kit
CY-8068 CircuLex Anti-CML human autoantibody ELISA Kit
CY-8069 CircuLex Anti-CML rat autoantibody ELISA Kit
CY-R2052 CML-BSA/Nε-(Carboxymenthyl)lysine-BSA
CY-R2053 CML-OVA/Nε-(carboxymethyl)lysine-OVA
CY-R2054 CEL-BSA/Nε-(carboxyethyl)lysine-BSA
CY-R2055 CEL-OVA/Nε-(carboxyethyl)lysine-OVA
CY-R2066 CML-HSA/Nε-(Carboxymethyl)lysine-HSA
CY-R2067 CEL-HSA/Nε-(Carboxymethyl)lysine-HSA
使用文献 使用文献募集中!本製品を使って論文を発表されましたら是非お知らせください。
  1. Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertility and Sterility. 94, 694-700 (2010)(PMID:19376511)
  1. Moriyama T et al. Involvement of advanced glycation end-products, pentosidine and N-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats. Toxicology. 268, 89-97 (2010)(PMID:20004697)
  1. Xianwen Yi et al. α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. Journal of Diabetes and its Complications. 25, 193-201 (2011)(PMID:20801062)
  1. Bao W et al. Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. Am J Physiol Cell Physiol. 299, C1212-C1219 (2010)(PMID:20810913)
  1. Zuwa?a-Jagie??o J et al. Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis. Acta Biochim Pol. 58, 59-65 (2011)(PMID:21403920)
  1. Karimi J et al. Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men. Diabetes Res Clin Pract. 91, 61-6 (2011)(PMID:20970866)
  1. Lance A et al. Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor. Diabetes. 60, 2285-2294 (2011)(PMID:21810592)
  1. Coughlan MT et al. Advanced Glycation Urinary Protein-Bound Biomarkers and Severity of Diabetic Nephropathy in Man. Am J Nephrol. 34, 347-355 (2011)(PMID:21876347)
  1. Meloche J et al. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol. 31, 2114-24 (2011)(PMID:21680901)
  1. Pettersson C et al. LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome. J Intern Med. 269, 306-21 (2011)(PMID:21205019)
  1. Nemoto S et al. Aminoguanidine normalizes ET-1-induced aortic contraction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats by suppressing Jab1-mediated increase in ET(A)-receptor expression.; Peptides. 33, 109-19 (2012)(PMID:22154739)
  1. Tahara N et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther. 30, 42-8 (2012)(PMID:20626403)
  1. Han D et al. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes. Genes Cells. 18, 302-14 (2013)(PMID:23410183)
  1. Machado-Lima A et al. Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport. Diabetes Metab Res Rev. 29, 66-76 (2013)(PMID:23015358)
  1. Boschetto P et al. Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD. Eur J Clin Invest. 43, 562-9 (2013)(PMID:23590548)
  1. Aoki C et al. Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy. Lab Invest. 93, 1170-83 (2013)(PMID:23979426)
  1. Munesue S et al. Low-molecular weight fractions of Japanese soy sauce act as a RAGE antagonist via inhibition of RAGE trafficking to lipid rafts. Food Funct. 4, 1835-42 (2013)(PMID:24191276)
  1. Malarde L et al. Endurance training and insulin therapy need to be associated to fully exert their respective beneficial effects on oxidant stress and glycemic regulation in diabetic rats. Free Radic Res. 48, 412-9 (2014)(PMID:24393032)
  1. Machado-Lima A et al. In type 2 diabetes mellitus glycated albumin alters macrophage gene expression impairing ABCA1-mediated cholesterol efflux. J Cell Physiol. 230, 1250-7 (2014)(PMID:25413254)
製品
カテゴリー
分野
代謝
この製品に関するお問い合わせをする

※在庫につきましては2017年06月26日 01時30分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。